Can-Fite BioPharma Ltd. Basic Shares Outstanding (Weighted Average)
Can-Fite BioPharma Ltd. (CANF) reported Basic Shares Outstanding (Weighted Average) of 1.65 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-03-26
| Period end | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 1.65M shares 20-F · filed 2026-03-26 | ||
| 2025-06-30 | 3.41B shares 6-K · filed 2025-08-28 | ||
| 2024-12-31 | 725.31K shares 20-F · filed 2026-03-26 | 2.18B shares 20-F · filed 2025-04-14 | |
| 2024-06-30 | 1.82B shares 6-K · filed 2025-08-28 | ||
| 2023-12-31 | 426.11K shares 20-F · filed 2026-03-26 | 1.28B shares 20-F · filed 2024-03-28 | |
| 2023-06-30 | 1.20B shares 6-K · filed 2024-08-29 | ||
| 2022-12-31 | 815.75M shares 20-F · filed 2025-04-14 | ||
| 2022-06-30 | 815.75M shares 6-K · filed 2023-08-31 | ||
| 2021-12-31 | 553.08M shares 20-F · filed 2024-03-28 | ||
| 2021-06-30 | 500.01M shares 6-K · filed 2022-08-25 | ||
| 2020-12-31 | 358.41M shares 20-F · filed 2023-03-30 |